Skip to main content
WVE
NASDAQ Life Sciences

Wave Life Sciences' WVE-006 Achieves MZ-Like Phenotype in AATD Trial, Reducing Harmful Z-AAT by 71%

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$6.62
Mkt Cap
$1.231B
52W Low
$5.02
52W High
$21.73
52W Position info
32% above low
Off High info
70% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

WVE sits 32% above its 52-week low of $5.02.

Summary

Wave Life Sciences announced highly positive updated data from its RestorAATion-2 Phase 1b/2a trial for WVE-006, its RNA editing oligonucleotide for alpha-1 antitrypsin deficiency (AATD). The data demonstrated WVE-006 achieved an MZ-like phenotype, generating healthy M-AAT (64% of total AAT) and significantly reducing harmful Z-AAT by 71% in the biweekly cohort, with consistent effects in monthly dosing. The drug was also well-tolerated, showed no liver toxicities, and restored dynamic AAT production, addressing both lung and liver manifestations of AATD. This strong clinical update is highly material for a clinical-stage biotech, indicating significant progress for a key pipeline asset. The company is on track for FDA feedback on a potential accelerated approval pathway by mid-2026, which will be the next major catalyst for the stock.

At the time of this announcement, WVE was trading at $6.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $5.02 to $21.73. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

WVE - Latest Insights

WVE
Oct 27, 2026, 7:50 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.42
Real-time Price: $3.28 info
Change: -$0.140 (-4%) info
Market Cap: $635.077M info
WVE
Oct 27, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.45
Real-time Price: $3.28 info
Change: -$0.170 (-5%) info
Market Cap: $635.077M info
WVE
Oct 01, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.71
Real-time Price: $3.28 info
Change: -$0.430 (-12%) info
Market Cap: $635.077M info
WVE
Sep 23, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.50
Real-time Price: $3.28 info
Change: -$1.22 (-27%) info
Market Cap: $635.077M info
WVE
Aug 07, 2026, 4:52 PM EDT
Filing Type: 8-K12B
Importance Score:
7
Price at Filing: $6.14
Real-time Price: $3.28 info
Change: -$2.86 (-47%) info
Market Cap: $635.077M info